How can biotech companies secure lab systems and research environments?
Biotech companies secure lab systems and research environments through network segmentation, access controls, continuous monitoring, incident response planning, and protection of scientific data, laboratory instruments, LIMS, and ELN platforms. A structured cybersecurity strategy helps reduce operational disruption, protect discoveries, and strengthen business resilience throughout the research lifecycle.
Table of contents
Why are lab systems and research environments attractive cyberattack targets?
Lab systems and research environments are attractive targets because they contain proprietary drug discovery data, intellectual property, clinical information, genomic research assets, and sensitive operational information.
Threat actors commonly target:
- Research findings
- Drug development data
- Clinical trial information
- Laboratory credentials
- Scientific collaboration platforms
- Manufacturing preparation systems
Successful attacks can result in:
- Intellectual property theft
- Operational downtime
- Regulatory complications
- Delayed research milestones
- Financial losses
- Reputational damage
Biotech companies that understand the value of their scientific assets can better prioritize protections around the systems that support innovation and discovery.
What systems should biotech companies prioritize for protection?
Biotech organizations should prioritize systems that directly support research, experimentation, data management, and business operations. Attention should be given to platforms that support scientific workflows, research data integrity, laboratory operations, and regulated activities in accordance with GMP, GCP, and broader GxP-regulated environments.
Common high-priority assets include:
- Laboratory information management systems (LIMS)
- Electronic laboratory notebooks (ELN)
- Scientific instruments
- Connected laboratory equipment
- Research databases and data lakes
- Cloud research platforms
- Identity and access management systems
- File storage environments
- Scientific instruments and file-sharing platforms
- Research data integrity systems and repositories
The table below illustrates common priorities.
System type | Primary risk | Security priority |
LIMS | Data manipulation | Critical |
ELN platforms | Intellectual property exposure | Critical |
Laboratory instruments | Operational disruption | High |
Research databases | Data theft | Critical |
Cloud environments | Unauthorized access | High |
Collaboration platforms | Credential compromise | High |
Biotech security teams that classify critical assets gain greater visibility into where protection efforts deliver the greatest value.
How do biotech companies secure LIMS, ELN, and research data platforms?
Biotech companies secure Laboratory Information Management Systems (LIMS), Electronic Laboratory Notebooks (ELN), and research data platforms through layered controls that protect sensitive scientific information, intellectual property, and regulated records. These systems frequently support scientific workflows, sample management, quality processes, and research data integrity requirements.
Important controls include:
- Multi-factor authentication
- Role-based access controls
- Continuous activity monitoring
- Audit trail retention
- Encryption of sensitive data
- Access review processes
- Backup validation procedures
Organizations should regularly review user permissions and monitor access activity to help reduce the risk of unauthorized changes, data exposure, or compromise of critical scientific information.
How does network segmentation improve laboratory security?
Network segmentation improves laboratory security by limiting communication between systems and reducing the impact of a compromise. Rather than allowing unrestricted connectivity, organizations separate environments based on function and risk.
Segmentation is especially important for organizations operating laboratory information management systems (LIMS), electronic laboratory notebooks (ELN), and laboratory equipment that support research data integrity requirements. Effective segmentation approaches include:
- Separating laboratory networks from corporate networks
- Isolating scientific instruments
- Restricting access to research repositories
- Segmenting development environments
- Creating dedicated zones for vendors and contractors
For example, a managed security provider, such as Single Point of Contact, might recommend separating laboratory equipment from general office infrastructure to reduce opportunities for lateral movement during an attack. Proper network separation limits lateral movement, improves containment, and reduces operational disruption during security events.
What access controls help protect research environments?
Access governance helps ensure researchers, contractors, and third-party partners receive only the permissions required for their responsibilities. Strong identity controls are particularly important for protecting access to LIMS platforms, ELN systems, research databases, and cloud applications that support scientific workflows.
Key controls include:
- Multi-factor authentication
- Role-based access permissions
- Privileged account management
- Conditional access policies
- Regular access reviews
- Centralized identity management
Scientists, laboratory staff, contractors, vendors, and external collaborators frequently require different permission levels. Granting permissions based on job responsibilities reduces unnecessary exposure while supporting operational efficiency. Organizations that align access privileges with business requirements create stronger protection around sensitive scientific assets.
Why is continuous security monitoring important for biotech organizations?
Continuous security monitoring helps identify suspicious activity before it becomes a significant security event. Monitoring can help detect unauthorized access attempts, unusual activity within LIMS and ELN platforms, and potential threats that could affect research data integrity.
Continuous monitoring supports:
- Threat detection
- Incident investigation
- Alert validation
- Log analysis
- Behavioral monitoring
- Rapid escalation
Managed security services, such as Single Point of Contact, can serve as an example of how organizations extend visibility without building a full internal security operations center. Earlier detection helps security teams investigate threats faster and minimize interruptions to research activities.
How do we monitor systems that cannot run EDR agents?
Many laboratory instruments, specialized workstations, and legacy systems cannot support endpoint detection and response (EDR) software because of vendor restrictions, performance limitations, or operational requirements. Organizations must use alternative monitoring approaches to maintain visibility into these environments.
Common monitoring strategies include:
- Network traffic analysis
- Security log collection
- Network intrusion detection systems
- User activity monitoring
- Asset behavior analysis
- Segmentation-based monitoring
Organizations that combine device isolation with network-level visibility are often better positioned to identify suspicious activity involving systems that cannot support modern endpoint security tools.
How can biotech companies secure laboratory instruments and legacy systems?
Biotech companies secure laboratory instruments and legacy systems through compensating controls when direct security updates are unavailable. Many laboratory instruments were designed for scientific accuracy rather than modern cyber defense requirements. The challenge is particularly common in research laboratories, GxP-regulated environments, and manufacturing-adjacent operations where specialized equipment remains in service for many years.
Recommended protections include:
- Network isolation
- Strict access controls
- Application allowlisting
- Device monitoring
- Vulnerability assessments
- Secure remote access procedures
Rather than relying solely on software updates, organizations reduce risk by limiting exposure and increasing visibility around device activity. These safeguards support uninterrupted experimentation while reducing exposure across critical laboratory assets.
How can a biotech secure legacy lab equipment?
Biotech companies secure legacy laboratory equipment by implementing compensating controls that reduce exposure when direct security updates are unavailable. Many scientific instruments remain operational for years and cannot be upgraded without affecting laboratory workflows.
Recommended protections include:
- Network segmentation
- Restricted internet access
- Access control enforcement
- Device activity monitoring
- Application allowlisting
- Secure remote access controls
- Vendor access management
Compensating safeguards help reduce risk while maintaining operational continuity for laboratory systems that remain critical to research activities.
How do biotech companies secure remote researchers and distributed teams?
Biotech companies secure remote researchers through identity controls, endpoint protections, secure connectivity, and monitoring capabilities that help protect access to research systems and sensitive data regardless of location.
Key safeguards include:
- Multi-factor authentication
- Managed endpoint protection
- Secure remote access technologies
- Conditional access policies
- Device compliance requirements
- User activity monitoring
Organizations should apply consistent security standards across office, laboratory, home, and travel environments to help reduce the risk of unauthorized access and data exposure.
How can biotech companies monitor cloud and SaaS security risks?
Biotech companies monitor cloud and SaaS security risks through continuous visibility into user activity, access permissions, configuration settings, and data-sharing practices. Research data, collaboration platforms, and regulated information frequently reside within cloud environments that require ongoing oversight.
Important monitoring activities include:
- Cloud activity logging
- Access governance reviews
- Configuration assessments
- Data-sharing audits
- Privileged access monitoring
- Third-party application reviews
Organizations that understand where scientific data resides, who can access it, and how information is shared are better positioned to reduce cloud-related security risks while supporting collaboration and research productivity.
What role does incident response play in protecting research operations?
Incident response helps organizations contain, investigate, and recover from security events with minimal disruption. A biotech-focused incident response plan should address:
- Research data compromise
- Laboratory system outages
- Credential theft
- Ransomware incidents
- Third-party security events
- Regulatory notification requirements
Preparation activities include:
- Define response procedures
- Assign responsibilities
- Conduct tabletop exercises
- Test communication plans
- Document recovery processes
Biotech companies that prepare before an incident occurs are better positioned to protect research continuity and restore operations efficiently.
How do compliance requirements influence biotech cybersecurity programs?
Regulatory frameworks help define expectations for data integrity, auditability, access management, and protection of sensitive scientific information. Relevant frameworks and regulations can include:
- FDA 21 CFR Part 11
- HIPAA
- NIST Cybersecurity Framework
- ISO 27001
- SOC 2
- State privacy regulations
Security initiatives should support both compliance objectives and practical risk reduction goals. For example, organizations working with managed security providers, such as Single Point of Contact, frequently align monitoring, logging, and access management capabilities with broader compliance initiatives.
Integrating security and compliance efforts creates a stronger foundation for protecting sensitive research activities.
How should biotech companies build a long-term security strategy?
Biotech companies should build a long-term security strategy by focusing on risk management, visibility, governance, and operational maturity. Effective programs align cybersecurity investments with scientific workflows, research data integrity objectives, laboratory operations, and compliance obligations across both research and GxP-regulated environments.
An effective roadmap typically includes:
- Identify critical assets
- Assess environmental risks
- Strengthen access controls
- Segment high-value systems
- Implement continuous monitoring
- Develop incident response capabilities
- Align with regulatory requirements
- Review and improve controls regularly
Security investments deliver greater value when they support research productivity, intellectual property protection, and operational resilience. A structured cybersecurity roadmap helps biotech companies protect valuable scientific assets without slowing innovation.
Building a sustainable cybersecurity strategy for biotech
Securing biotech lab systems and research environments requires a combination of technical controls, operational processes, and ongoing visibility. Protecting scientific assets involves more than safeguarding data. It also includes maintaining research continuity, supporting compliance objectives, and reducing exposure to evolving threats.
Organizations that focus on asset protection, access governance, network segmentation, continuous monitoring, and incident preparedness are better positioned to safeguard intellectual property and maintain confidence in their research operations.
Where can biotech companies learn more about managed security providers?
Organizations can learn how managed security services support biotech environments through Single Point of Contact’s biotech IT and security services. Services include 24×7 monitoring, threat detection, incident response, compliance support, Microsoft 365 security, and protection of research data and intellectual property.
Related Articles
How do biotech companies protect intellectual property from cyber threats?
Intellectual property is among the most valuable assets in biotech. Discover how organizations monitor research data, detect credential compromise, secure collaborations, identify insider threats, and strengthen protection for scientific discoveries across laboratory and cloud environments.
Biotech managed security resource center
This hub provides an overview of biotech cybersecurity, including managed security services, MDR, managed SOC, security operations maturity, intellectual property protection, ransomware preparedness, compliance requirements, audit readiness, vendor risk management, and strategies for securing research environments.
Biotech cybersecurity services overview
This page provides an overview of cybersecurity, compliance, cloud, and managed IT services for biotech companies. Learn how life sciences organizations protect research data, support laboratory environments, strengthen operational resilience, meet regulatory requirements, and align technology strategies with scientific and business objectives.
Frequently asked questions
When should biotech companies implement cybersecurity controls?
Yes. Cybersecurity risks exist throughout the research lifecycle, not only after commercialization. Intellectual property, laboratory systems, and scientific datasets can be valuable targets during early-stage development. Implementing foundational controls early reduces risk while supporting future growth and regulatory readiness.
How can biotech companies protect intellectual property from cyber threats?
Protection starts with identifying sensitive research assets, including LIMS platforms, ELN systems, research databases, and proprietary scientific workflows, then applying layered controls around those environments. Access restrictions, multi-factor authentication, network segmentation, monitoring, encryption, and incident response planning all help safeguard proprietary discoveries and research outcomes against unauthorized access or theft.
Is continuous monitoring necessary for small biotech companies?
Yes. Smaller organizations face many of the same threats as larger enterprises, but frequently have fewer internal resources. Investors, auditors, and partners increasingly expect evidence of ongoing threat detection capabilities. Managed security services, such as Single Point of Contact, can provide visibility, threat detection, and escalation capabilities that support stronger protection without requiring a large internal team.
What are the biggest cybersecurity risks in laboratory environments?
Common risks include credential compromise, ransomware, intellectual property theft, vulnerable scientific instruments, third-party access issues, and insufficient visibility into network activity. Addressing these risks requires a combination of technology controls, governance processes, and ongoing monitoring.
How often should biotech companies review their cybersecurity programs?
Most organizations should review cybersecurity controls at least annually and after significant business, technology, or regulatory changes. Regular assessments help identify gaps, validate security investments, and ensure protections remain aligned with evolving threats and operational requirements.
How do biotech companies secure LIMS and ELN platforms?
Biotech companies secure Laboratory Information Management Systems (LIMS) and Electronic Laboratory Notebooks (ELN) by implementing strong access controls, multi-factor authentication, continuous monitoring, network segmentation, and data protection measures. These platforms frequently contain proprietary research, experimental results, regulatory records, and other sensitive scientific information that require heightened security.
About the author
Gregory Morawietz is a technology executive with experience evaluating and comparing IT and security service models. He helps organizations understand trade-offs among delivery models in terms of cost, scalability, and operational impact. His work includes supporting organizations in regulated industries such as life sciences, healthcare, and technology. Gregory brings a structured, practical perspective to the comparison of technologies and service models in a complex and evolving landscape.